Cablivi (caplacizumab)

pCPA File Number: 22477
Negotiation Status:
Negotiations were not pursued
Indication(s):
acquired thrombotic thrombocytopenic purpura (aTTP)
Sponsor/Manufacturer:
sanofi-aventis Canada Inc.
CDA-AMC Project Number:
SR0736-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: